RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
4D Molecular Therapeutics - Stock

4D Molecular Therapeutics ROA 2024

4D Molecular Therapeutics ROA

-0.3

Ticker

FDMT

ISIN

US35104E1001

In 2024, 4D Molecular Therapeutics's return on assets (ROA) was -0.3, a -27.74% increase from the -0.41 ROA in the previous year.

4D Molecular Therapeutics Aktienanalyse

What does 4D Molecular Therapeutics do?

4D Molecular Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding 4D Molecular Therapeutics's Return on Assets (ROA)

4D Molecular Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing 4D Molecular Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider 4D Molecular Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in 4D Molecular Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about 4D Molecular Therapeutics Stock

What is the Return on Assets (ROA) of 4D Molecular Therapeutics this year?

The Return on Assets (ROA) of 4D Molecular Therapeutics is -0.3 undefined this year.

What was the ROA of 4D Molecular Therapeutics compared to the previous year?

The ROA of 4D Molecular Therapeutics has increased by -27.74% compared to the previous year.

What consequences do high ROA have for investors of 4D Molecular Therapeutics?

A high ROA is advantageous for investors of 4D Molecular Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in 4D Molecular Therapeutics?

A low ROA can be unfavorable for investors of 4D Molecular Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of 4D Molecular Therapeutics affect the company?

An increase in ROA of 4D Molecular Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of 4D Molecular Therapeutics impact the company?

A reduction in the ROA of 4D Molecular Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of 4D Molecular Therapeutics?

Some factors that can influence the ROA of 4D Molecular Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of 4D Molecular Therapeutics important for investors?

The ROA of 4D Molecular Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can 4D Molecular Therapeutics take to improve ROA?

To improve ROA, 4D Molecular Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does 4D Molecular Therapeutics pay?

Over the past 12 months, 4D Molecular Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 4D Molecular Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of 4D Molecular Therapeutics?

The current dividend yield of 4D Molecular Therapeutics is .

When does 4D Molecular Therapeutics pay dividends?

4D Molecular Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 4D Molecular Therapeutics?

4D Molecular Therapeutics paid dividends every year for the past 0 years.

What is the dividend of 4D Molecular Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 4D Molecular Therapeutics located?

4D Molecular Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von 4D Molecular Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 4D Molecular Therapeutics from 6/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2024.

When did 4D Molecular Therapeutics pay the last dividend?

The last dividend was paid out on 6/16/2024.

What was the dividend of 4D Molecular Therapeutics in the year 2023?

In the year 2023, 4D Molecular Therapeutics distributed 0 USD as dividends.

In which currency does 4D Molecular Therapeutics pay out the dividend?

The dividends of 4D Molecular Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 4D Molecular Therapeutics

Our stock analysis for 4D Molecular Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 4D Molecular Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.